Evangelista’s appearance on New to The Street TV highlighted Trinity’s three-decade track record in the life sciences sector, now pivoting toward the integration of human judgment and machine intelligence. The CEO emphasized that the primary hurdle for most firms remains legacy data environments, which often lack the structure required for effective AI deployment. Trinity seeks to bridge this gap through its TrinityEDGE platform, designed to transform raw data into actionable commercial insights.
Trinity CEO Scott Evangelista on AI Integration in Life Sciences
Broadcasting from the floor of the New York Stock Exchange, Trinity CEO Scott Evangelista challenged the life sciences industry to shift its focus from experimental AI pilots toward practical commercial application. He argued that technology only delivers measurable value when fused with decades of institutional human expertise.
During the interview, Evangelista detailed how the company uses specific tools to move beyond theory. The AI Readiness Benchmark assesses a firm’s current infrastructure against industry peers, while the InsightsEDGE Digital Twins tool allows brand teams to simulate physician and payer responses in near real time. By replacing weeks of traditional fieldwork with synthetic personas, the company aims to accelerate decision-making for pharmaceutical and biotech clients. As the firm marks its 30th anniversary, it continues to scale its operations, now employing 1,300 professionals across five continents to support complex product launches.
Comments (0)
No comments yet. Be the first!